SSelectStock

INDOUSIndo Us Biotech Limited

Metals · Agricultural Inputs · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

Indo Us Bio-Tech Limited engages in the production, processing, packing, and marketing of seeds in India. The company offers vegetable seeds, such as tomato, okra, bottle gourd, brinjal, carrot, cluster bean, bitter gourd, ridge gourd, cucumber, cabbage, radish, sponge gourd, pepper, chilly, sweet pepper, beet root, cow pea, corriander, onion, watermelon, musk melon, and flower seeds; cotton seeds; and oil seeds, including castor, groundnut, sesamum, mustard, and soyabean seeds. It also provides cumin and isabgul spices seeds; pulses seeds comprising val, gram, black gram, and green gram seeds; and cereals seeds consisting of wheat, maize, bajra, and pegeon pea seeds. It also exports its products. The company was incorporated in 2004 and is based in Ahmedabad, India.

78.24
1.63%
33Weak

Mkt Cap
₹157 Cr
P/E
13.7
P/B
1.7
Div Yield
0.00%
52W High
₹159.00
52W Low
₹70.00

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)157.40
P/E13.73
P/B1.70
PEG
ROE %14.20
ROCE %12.40
Debt / Equity0.40
EPS5.70
Revenue Growth %7.20
Profit Growth %-35.70
Dividend Yield %0.00
Promoter Holding %75.49
FII Holding %0.00
DII Holding %
Beta0.23

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on INDOUS — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

AVOIDConviction 70%

Why avoid

  • Overall evidence is weak (AlgoScore 33/100)
  • Revenue growth: 7.2% YoY
  • Profit growth: -35.7% YoY
  • RSI: 40
  • Price vs EMA21: below

Bull case

  • Debt/Equity: 0.40
  • Promoter holding: 75.5%
  • Valuation vs sector: P/E 13.7 vs sector 21.6
  • MACD: fresh bullish crossover

Bear case

  • Revenue growth: 7.2% YoY
  • Profit growth: -35.7% YoY
  • RSI: 40
  • Price vs EMA21: below

Key risks

  • Elevated volatility / drawdown profile — size positions accordingly
  • Momentum is fading versus the broader market
  • Revenue growth: 7.2% YoY
  • Profit growth: -35.7% YoY

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹78.24
Stop Loss
₹69.30
risk 11.4%
Target 1 (1.5R)
₹91.65
+17.1%
Target 2 (3R)
₹105.06
+34.3%
Support (20d)
₹70.00
Resistance (52w)
₹159.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹8.94/share
ATR (volatility)
₹4.60
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹4.60). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental53
Technical35
Momentum16
Risk (safety)18

Peers — Metals

BHAGYANGR 2.23%
80
SAMBHV 1.08%
78
WELCORP 3.61%
78
VSSL 1.39%
77
RSL 1.82%
77
ARIES 1.49%
76